August 6, 2025 · Form 4 insider transaction
WILSON TROY EDWARD bought 7,500 shares of Atrium Therapeutics, Inc. at $12.48 per share, a transaction worth $93.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.